Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · December 21, 2017

Effect of PCSK9 Inhibitors on Clinical Outcomes in Patients With Hypercholesterolemia

Journal of the American Heart Association

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the American Heart Association
Effect of PCSK9 Inhibitors on Clinical Outcomes in Patients With Hypercholesterolemia: A Meta-Analysis of 35 Randomized Controlled Trials
J Am Heart Assoc 2017 Dec 09;[EPub Ahead of Print], A Karatasakis, BA Danek, J Karacsonyi, BV Rangan, MK Roesle, T Knickelbine, MD Miedema, H Khalili, Z Ahmad, S Abdullah, S Banerjee, ES Brilakis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading